Phase 3 Results of Xilonix Immunotherapy in Advanced Colorectal Cancer Patients Presented by XBiotech
News
XBiotech recently presented positive data from its pivotal Phase 3 clinical trial of Xilonix, the company’s monoclonal antibody immunotherapy for advanced colorectal cancer (CRC), at the 18th European Society of Medical Oncology ... Read more